Pri-Med Jacksonville

Jacksonville, FL | November 15-16, 2018

Prime F. Osborn III Convention Center

Putting the Patient First: Best Practices in Managing Cardiovascular Risk and Other Modifiable Risk Factors


Cardiovascular disease, obesity, and diabetes are closely linked, physiologically and epidemiologically. This session reviews the latest evidence on the management of hypertension, dyslipidemia, and cardiovascular risk in the patient with diabetes. Learn to assess cardiovascular risk, interpret guidelines, and optimize therapy for your complex cardiometabolic patients. Lastly, understand the role that newer diabetes therapies can play in reducing cardiovascular risk in patients with diabetes.

Learning Objectives

Apply current evidence and proven clinical strategies to reduce comorbid cardiovascular risk and complications of diabetes, including heart failure, hypertension, dyslipidemia, coronary artery disease, and stroke

Describe the pathophysiologic links between diabetes and cardiovascular disease

Evaluate potential cardiovascular impact when selecting antihyperglycemic agents


Download a PDF of the presented slides.



Ty J. Gluckman, MD, FACC, FAHA

Ty J. Gluckman, MD, FACC, FAHA, is medical director of the Center for Cardiovascular Analytics, Research, and Data Science (CARDS) at the Providence St. Joseph Heart Institute in Portland, Oregon and an adjunct faculty member of the Ciccarone Center ...

View Full Bio

Educational Partners

Commercial Supporters

Lilly. For further information concerning Lilly grant funding visit, Merck & Co., Inc., Novo Nordisk Inc., Sanofi US